{"cik":"0001598599","ticker":"IPHA","name":"Innate Pharma SA","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"I0","fiscal_year_end":"1231","first_filing_date":"2026-05-12","last_filing_date":"2026-09-10","url":"/sec/cik-0001598599","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0000950103-26-009261","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-06-22","title":"SCHEDULE 13G/A — Innate Pharma SA — 2026-06-22","url_slug":"/sec/cik-0001598599/schedule-13g-a/0000950103-26-009261","edgar_url":"https://www.sec.gov/Archives/edgar/data/1598599/0000950103-26-009261-index.html"},{"accession_number":"0001628280-26-033831","form_type":"6-K","form_type_family":"current","doc_date":"2026-05-12","title":"6-K — Innate Pharma SA — 2026-05-12","url_slug":"/sec/cik-0001598599/6-k/0001628280-26-033831","edgar_url":"https://www.sec.gov/Archives/edgar/data/1598599/0001628280-26-033831-index.html"}],"related_endpoints":{"profile":"/sec/IPHA/profile","timeline":"/sec/IPHA/timeline","peers":"/sec/IPHA/peers","insider_pulse":"/sec/IPHA/insider-pulse","insider_summary":"/sec/IPHA/insider-summary","insider_transactions":"/sec/IPHA/insider-transactions","form144":"/sec/IPHA/form144","holdings_as_filer":"/sec/IPHA/holdings","financial_facts":"/sec/IPHA/financial-facts","derivatives":"/sec/IPHA/derivatives","officers":"/sec/IPHA/officers","insider_network":"/sec/IPHA/insider-network","risk_flags":"/sec/IPHA/risk-flags","filings":"/sec/IPHA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=IPHA"}}